These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


163 related items for PubMed ID: 7137978

  • 1. [Acute toxic action of combinations of antibiotics with isoniazid].
    Ziia AV, Sokolova GB, Lebedeva MN.
    Antibiotiki; 1982; 27(7):535-9. PubMed ID: 7137978
    [Abstract] [Full Text] [Related]

  • 2. Subchronic toxicity of human immunodeficiency virus and tuberculosis combination therapies in B6C3F1 mice.
    Rao GN, Lindamood C, Heath JE, Farnell DR, Giles HD.
    Toxicol Sci; 1998 Sep; 45(1):113-27. PubMed ID: 9848118
    [Abstract] [Full Text] [Related]

  • 3. Curative effect of a course of monotherapy with rifampicin, isoniazid or streptomycin subsequent to combination treatment in murine tuberculosis.
    Kradolfer F, Schnell R.
    Arzneimittelforschung; 1973 Oct; 23(10):1462-4. PubMed ID: 4591314
    [No Abstract] [Full Text] [Related]

  • 4. [Effectiveness of the rapid intravenous administration of rifampicin and isoniazid and of the intramuscular administration of streptomycin in disseminated destructive pulmonary tuberculosis in dogs].
    Bondarev IM, Ivanov VL, Novoselova VP, Kovaleva LA, Shtegel'man LA.
    Antibiotiki; 1984 Jun; 29(6):430-4. PubMed ID: 6476805
    [Abstract] [Full Text] [Related]

  • 5. [Results of planned treatment of tuberculosis, under field conditions, with a therapeutic regimen consisting of isoniazid, rifampicin and streptomycin].
    González Montaner LJ, Palma Beltrán O, Abbate E, Dambrosi A, Mosca C.
    Bull Int Union Tuberc; 1983 Jun; 58(2):108-10. PubMed ID: 6360262
    [No Abstract] [Full Text] [Related]

  • 6. [Urinary excretion of rifampicin in kidney failure when administered alone or together with isoniazid].
    Titarenko OT, Vakhmistrova TI, Perova TL.
    Antibiotiki; 1983 Sep; 28(9):698-702. PubMed ID: 6638984
    [Abstract] [Full Text] [Related]

  • 7. Influence of immunosuppression on the action of antimycobacterial drugs in experimental tuberculosis. I. Effects of isoniazid, rifampicin and streptomycin on the survival of tuberculous mice immunosuppressed by azathioprine (Imuran).
    Trnka L, Kvapilová M, Mison P.
    Chemotherapy; 1976 Sep; 22(6):353-61. PubMed ID: 954481
    [Abstract] [Full Text] [Related]

  • 8. [Hepatotoxic effect of a combination of pyrazinamide with isoniazid and rifampicin].
    Slivka IuI, Klimniuk EV, Tabachuk OE.
    Probl Tuberk; 1989 Sep; (4):39-42. PubMed ID: 2734263
    [Abstract] [Full Text] [Related]

  • 9. Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels.
    Agrawal S, Singh I, Kaur KJ, Bhade SR, Kaul CL, Panchagnula R.
    Int J Pharm; 2004 May 19; 276(1-2):41-9. PubMed ID: 15113612
    [Abstract] [Full Text] [Related]

  • 10. Bioavailability of rifampicin, isoniazid and pyrazinamide from fixed-dose combination capsules.
    Zwolska Z, Niemirowska-Mikulska H, Augustynowicz-Kopec E, Walkiewicz R, Stambrowska H, Safianowska A, Grubek-Jaworska H.
    Int J Tuberc Lung Dis; 1998 Oct 19; 2(10):824-30. PubMed ID: 9783530
    [Abstract] [Full Text] [Related]

  • 11. [Comparative hepatic toxicity of isoniazid, rifampicin and ethambutol].
    Skakun NP, Tabachuk OE.
    Probl Tuberk; 1991 Oct 19; (10):77-9. PubMed ID: 1788241
    [Abstract] [Full Text] [Related]

  • 12. [Rifomycin in continuous and intermittent combined treatment of experimental tuberculosis in mice].
    Grumbach F.
    Acta Tuberc Pneumol Belg; 1969 Oct 19; 60(3):390-6. PubMed ID: 5371670
    [No Abstract] [Full Text] [Related]

  • 13. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR, Agarwal SK, Shah KV.
    Int J Tuberc Lung Dis; 2002 Dec 19; 6(12):1098-101. PubMed ID: 12546118
    [Abstract] [Full Text] [Related]

  • 14. [Activity of intermittently administered rifampicin and cyclopentyl rifamycin (or DL473) on experimental tuberculosis in the mouse].
    Truffot-Pernot C, Grosset J, Bismuth R, Lecoeur H.
    Rev Fr Mal Respir; 1983 Dec 19; 11(6):875-82. PubMed ID: 6669798
    [Abstract] [Full Text] [Related]

  • 15. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M, Bek E.
    Pneumonol Pol; 1980 Jul 19; 48(7):469-79. PubMed ID: 7433146
    [No Abstract] [Full Text] [Related]

  • 16. [Hepato-biliary effect of the rifomycin-isoniazid combination. II. Histological study on tuberculized mice].
    Balea T, Marche C, Marche J.
    Therapie; 1970 Jul 19; 25(1):125-30. PubMed ID: 5436794
    [No Abstract] [Full Text] [Related]

  • 17. [Glycolysis components and carbohydrate metabolic enzyme activity of the blood under long-term action of rifampicin and isoniazid].
    Khomenko AG, Vysochina IV, Efimova LN, Kuz'mina NV.
    Biull Eksp Biol Med; 1982 Apr 19; 93(4):54-7. PubMed ID: 7082803
    [Abstract] [Full Text] [Related]

  • 18. Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations.
    Panchagnula R, Singh I, Kaur KJ, Kaul CL.
    Methods Find Exp Clin Pharmacol; 1999 Nov 19; 21(9):625-8. PubMed ID: 10669909
    [Abstract] [Full Text] [Related]

  • 19. [Experimental study of the toxic effect of combinations of tobramycin and carbenicillin].
    Iakushkina IV, Filippos'iants ST, Shevniuk LA.
    Antibiotiki; 1984 May 19; 29(5):361-5. PubMed ID: 6742807
    [Abstract] [Full Text] [Related]

  • 20. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG, Chernousova LN, Andreevskaia SN, Nikolaeva GM.
    Probl Tuberk Bolezn Legk; 2004 May 19; (3):32-7. PubMed ID: 15338898
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.